Convalescent Plasma News and Research

RSS
Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

Understanding the evolutionary mutational patterns of chronic SARS-CoV-2 infection

Understanding the evolutionary mutational patterns of chronic SARS-CoV-2 infection

Encouraging in vitro results with SARS-CoV-2-spike-specific polyclonal antibody fragments

Encouraging in vitro results with SARS-CoV-2-spike-specific polyclonal antibody fragments

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

A comparison of COVID-19 vaccines by neutralizing antibody potency

A comparison of COVID-19 vaccines by neutralizing antibody potency

Molecular characteristics of SARS-CoV-2 variants enabling antibody escape

Molecular characteristics of SARS-CoV-2 variants enabling antibody escape

The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

Study demonstrates associations between COVID-19 symptom presentation and antibody assay reactivity

Study demonstrates associations between COVID-19 symptom presentation and antibody assay reactivity

Study shows IgA antibodies play a significant role in neutralizing SARS-CoV-2

Study shows IgA antibodies play a significant role in neutralizing SARS-CoV-2

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Greater neutralizing titers observed in vaccinated individuals with breakthrough Omicron infection

Greater neutralizing titers observed in vaccinated individuals with breakthrough Omicron infection

Study finds that high-dose convalescent plasma does not improve outcomes for severe COVID-19

Study finds that high-dose convalescent plasma does not improve outcomes for severe COVID-19

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

Variants of SARS-CoV-2 and preventive strategies

Variants of SARS-CoV-2 and preventive strategies

SARS-CoV-2 vaccination of convalescents suggested to boost neutralization capacity against variants

SARS-CoV-2 vaccination of convalescents suggested to boost neutralization capacity against variants

Study demonstrates that intra-host SARS-CoV-2 variants with reduced infectivity are developed during infection

Study demonstrates that intra-host SARS-CoV-2 variants with reduced infectivity are developed during infection

SARS-CoV-2 Delta sublineage AY.4.2 shows no increase in cell entry or antibody evasion

SARS-CoV-2 Delta sublineage AY.4.2 shows no increase in cell entry or antibody evasion